Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by University of Wisconsin, Madison.
Recruitment status was  Recruiting
Information provided by:
University of Wisconsin, Madison Identifier:
First received: January 6, 2009
Last updated: February 3, 2010
Last verified: February 2010

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.

Hepatitis C Virus

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by University of Wisconsin, Madison:

Biospecimen Retention:   Samples Without DNA

viral RNA

Estimated Enrollment: 30
Study Start Date: October 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

solid organ transplant patients


Inclusion Criteria:

  • HCV infected on immunosuppression
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00819026

United States, Wisconsin
University of Wisconsin Recruiting
Madison, Wisconsin, United States, 53706
Contact: Rob Striker, MD/PhD    608-263-2994   
Principal Investigator: Rob Striker, MD/PhD         
Sponsors and Collaborators
University of Wisconsin, Madison
Principal Investigator: Robert Striker University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Rob Striker, Assistant Professor of Medicine, university of Wisconsin Identifier: NCT00819026     History of Changes
Other Study ID Numbers: UWisHCV-1
Study First Received: January 6, 2009
Last Updated: February 3, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hepatitis A
Hepatitis C
Digestive System Diseases
Enterovirus Infections
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases processed this record on November 27, 2014